Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Modebadze, Tamara; Morgan, Nicola H.; Pérès, Isabelle A. A.; Hadid, Rebecca D.; Amada, Naoki; Hill, Charlotte; Williams, Claire; Stanford, Ian M.; Morris, Christopher M.; Jones, Roland S. G.; Whalley, Benjamin J.; Woodhall, Gavin L. (2016)
Publisher: Public Library of Science
Journal: PLoS ONE
Languages: English
Types: Article
Subjects: Epilepsy, Animal Models, Research Article, Population Metrics, Anatomy, Neural Networks, Trauma Medicine, Rodents, People and Places, Demography, Rats, Animals, Behavior, Neurology, Biology and Life Sciences, Computer and Information Sciences, Hippocampus, Animal Behavior, Neuroscience, Research and Analysis Methods, Medicine, Brain Damage, Critical Care and Emergency Medicine, Brain, Vertebrates, Q, Status Epilepticus, R, Population Biology, Model Organisms, Mammals, Science, Organisms, Death Rates, Medicine and Health Sciences, Zoology

Animal models of acquired epilepsies aim to provide researchers with tools for use in understanding the processes underlying the acquisition, development and establishment of the disorder. Typically, following a systemic or local insult, vulnerable brain regions undergo a process leading to the development, over time, of spontaneous recurrent seizures. Many such models make use of a period of intense seizure activity or status epilepticus, and this may be associated with high mortality and/or global damage to large areas of the brain. These undesirable elements have driven improvements in the design of chronic epilepsy models, for example the lithium-pilocarpine epileptogenesis model. Here, we present an optimised model of chronic epilepsy that reduces mortality to 1% whilst retaining features of high epileptogenicity and development of spontaneous seizures. Using local field potential recordings from hippocampus in vitro as a probe, we show that the model does not result in significant loss of neuronal network function in area CA3 and, instead, subtle alterations in network dynamics appear during a process of epileptogenesis, which eventually leads to a chronic seizure state. The model's features of very low mortality and high morbidity in the absence of global neuronal damage offer the chance to explore the processes underlying epileptogenesis in detail, in a population of animals not defined by their resistance to seizures, whilst acknowledging and being driven by the 3Rs (Replacement, Refinement and Reduction of animal use in scientific procedures) principles.

  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Goddard GV, McIntyre DC, Leech CK. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol, 1969; 25: 295-330. PMID: 4981856
    • 2. Louis ED, Williamson PD, Darcey TM. Chronic focal epilepsy induced by microinjection of tetanus toxin into the cat motor cortex. Electroencephalogr Clin Neurophysiol. 1990; 75:548-57. PMID: 1693899
    • 3. Tremblay E, Ben-Ari Y. Usefulness of parenteral kainic acid as a model of temporal lobe epilepsy. Rev Electroencephalogr Neurophysiol Clin. 1984; 14: 241-246. PMID: 6528079
    • 4. Turski WA, Cavalheiro EA, Schwarz M, Czuczwar SLJ, Kleinrok Z, Turski L. Limbic seizures produced by pilocarpine in rats: behavioral, electroencephalographic and neuropathological study. Behav Brain Res. 1983; 9: 315-335. PMID: 6639740
    • 5. Starzl TE, Niemer WT, Dell M, Forgrave PR. Cortical and subcortical electrical activity in experimental seizures induced by metrazol. J Neuropathol Exp Neurol. 1953; 12: 262-276. PMID: 13061974
    • 6. Sloviter RS. The neurobiology of temporal lobe epilepsy: too much information, not enough knowledge. C R Biol. 2005; 328: 143-153. PMID: 15771000
    • 7. Glien M, Brandt C, Potschka H, Voigt H, Ebert U, Löscher W. Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy. Epilepsy Res. 2001; 46: 111- 119. PMID: 11463512
    • 8. Curia GL, Longo D, Biagini G, Jones RSG, Avoli M. The pilocarpine model of temporal lobe epilepsy. J Neurosci Meth. 2008; 172: 143-157.
    • 9. Moser V. McCormick JP, Creason JP, MacPhail RC. Comparison of chlordimeform and carbaryl using a functional observational battery. Fundamental App Toxicol. 1988; 11; 189-206.
    • 10. Farrimond JA, Hill AJ, Jones NA, Stephens GJ, Whalley BJ, Williams CM. A cost-effective highthroughput digital system for observation and acquisition of animal behavioral data. Behav Res Meth. 2009; 41: 446-451.
    • 11. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972; 32: 281-294. PMID: 4110397
    • 12. Huang X, McMahon J, Huang Y. Rapamycin attenuates aggressive behavior in a rat model of pilocarpine-induced epilepsy. Neuroscience 2012; 215: 90-97. doi: 10.1016/j.neuroscience.2012.04.011 PMID: 22522471
    • 13. Polascheck N, Bankstahl M, Löscher W. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Exp Neurol. 2010; 224; 219-233. doi: 10.1016/j.expneurol.2010.03.014 PMID: 20353773
    • 14. Rice AC, Floyd CL, Lyeth BG, Hamm RJ, Delorenzo RJ. Status epilepticus causes long-term nmda receptor-dependent behavioural changes and cognitive deficits. Epilepsia 1998; 39: 1148-1157. PMID: 9821978
    • 15. Jope RS, Morrisett RA, Snead OC. Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats. Exp Neurol 1986; 91: 471-480. PMID: 3948956
    • 16. Arida RM, Fulvio AS, Clovis de Araujo P, Cavalheiro EA. The course of untreated seizures in the pilocarpine model of epilepsy. Epilepsy Res. 1999; 34: 99-107. PMID: 10210024
    • 17. Lemos T, Cavalheiro EA. Suppression of pilocarpine-induced status epilepticus and the late development of epilepsy in rats. Exp Brain Res. 1995; 102: 423-428. PMID: 7737389
    • 18. Jones RSG, Heinemann U. Synaptic and intrinsic responses of medial entorhinal cortical cells in normal and magnesium-free medium in vitro. J Neurophysiol. 2008; 59: 1476-1496.
    • 19. Cook LL, Persinger MA. "Subclinical" dosages of lithium and pilocarpine that do not evoke overt seizures affect long-term spatial memory but not learning in rats. Percept Mot Skills. (1998) 86(3 Pt 2):1288-90. PMID: 9700805
    • 20. Bajorat R, Wilde M, Sellmann T, Kirschstein T, Köhling R. Seizure frequency in pilocarpine-treated rats is independent of circadian rhythm. Epilepsia. 2011 Sep; 52(9):e118-22. doi: 10.1111/j.1528-1167. 2011.03200.x PMID: 21801169
    • 21. French JA, Williamson PD, Thadani VM, Darcey TM, Mattson RH, Spencer SS, et al. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann Neurol. 1993; 34: 774-780. PMID: 8250525
    • 22. Joy RM, Stark LG, Albertson TE. Dose-dependent proconvulsant and anticonvulsant actions of the alpha 2 adrenergic agonist, xylazine, on kindled seizures in the rat. Pharmacol Biochem Behav. 1983; 19: 345-350. PMID: 6314391
    • 23. Yang J, Woodhall GL, Jones RSG. Tonic facilitation of glutamate release by presynaptic NR2B-containing NMDA receptors is increased in the entorhinal cortex of chronically epileptic rats. J Neurosci. 2006; 26: 406-410. PMID: 16407536
    • 24. Thompson SE, Ayman G, Woodhall GL, Jones RSG. Depression of glutamate and GABA release by presynaptic GABAB receptors in the entorhinal cortex in normal and chronically epileptic rats. Neurosignals. 2006; 15: 202-215. PMID: 17215590
    • 25. Tatum WO. Artifact-related epilepsy. Neurology 2013; 80(1 Suppl 1): S12-25. doi: 10.1212/WNL. 0b013e3182797325 PMID: 23267041
    • 26. Samoriski GM, Applegate CD. Repeated generalized seizures induce time-dependent changes in the behavioral seizure response independent of continued seizure induction. J Neurosci. 1997; 17: 5581- 5590. PMID: 9204939
    • 27. Fujikawa DG. Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia. (1995) 36(2):186-95. PMID: 7821277
    • 28. Tang FR, Chen PM, Tang YC, Tsai MC, Lee WL. Two-methyl-6-phenylethynyl-pyridine (MPEP), a metabotropic glutamate receptor 5 antagonist, with low doses of MK801 and diazepam: a novel approach for controlling status epilepticus. Neuropharmacology. 2007; 53:821-831. PMID: 17904168
    • 29. Navarro Mora G, Bramanti P, Osculati F, Chakir A, Nicolato E, Marzola P, et al. Does pilocarpineinduced epilepsy in adult rats require status epilepticus? PLoS One. 2009; 4: e5759. doi: 10.1371/ journal.pone.0005759 PMID: 19503612
    • 30. Santi SA, Cook LL, Persinger MA, O'Connor RP. Normal spatial memory following postseizure treatment with ketamine: selective damage attenuates memory deficits in brain-damaged rodents. Int J Neurosci. (2001) 107(1-2):63-75. PMID: 11328682
    • 31. Karbowski LM, Parker GH, Persinger MA. Post-seizure drug treatment in young rats determines clear incremental losses of frontal cortical and hippocampal neurons: the resultant damage is similar to very old brains. Epilepsy Behav. (2013) A27(1):18-21.
  • Inferred research data

    The results below are discovered through our pilot algorithms. Let us know how we are doing!

    Title Trust
  • No similar publications.